MINGYI WANG

Dr. MINGYI WANG


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2020 in Gut
Verified
Journal Article
Open access
PDF file
YSY Song
Y Song
PLP Liu
P Liu
XSX L Shi
X L Shi
YCY L Chu
Y L Chu
JZJ Zhang
J Zhang
MWMINGYI WANG
MINGYI WANG

16 December 2019 in Folia Microbiologica
Verified
Journal Article
Closed access
PDF file
GLGang Li
Gang Li
MWMINGYI WANG
MINGYI WANG

12 February 2021 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
DXDa Xu
Da Xu
HXHanxiao Xu
Hanxiao Xu
YZYusen Zhang
Yusen Zhang
MWMINGYI WANG
MINGYI WANG
WCWei Chen
Wei Chen
RGRui Gao
Rui Gao
Background: Microbes are closely related to human health and diseases. Identification of disease-related microbes is of great significance for revealing the pathological mechanism of human diseases and understanding the interaction mechanisms between microbes and humans, which is also useful for the prevention, diagnosis and treatment of human diseases. Considering the known disease-related microbes are still insufficient, it is necessary to develop effective computational methods and reduce the time and cost of biological experiments.Methods: In this work, we developed a novel computational method called MDAKRLS to discover potential microbe-disease associations (MDAs) based on the Kronecker regularized least squares. Specifically, we introduced the Hamming interaction profile similarity to measure the similarities of microbes and diseases besides Gaussian interaction profile kernel similarity. In addition, we introduced the Kronecker product to construct two kinds of Kronecker similarities between microbe-disease pairs. Then, we designed the Kronecker regularized least squares with different Kronecker similarities to obtain prediction scores, respectively, and calculated the final prediction scores by integrating the contributions of different similarities.Results: The AUCs value of global leave-one-out cross-validation and 5-fold cross-validation achieved by MDAKRLS were 0.9327 and 0.9023 ± 0.0015, which were significantly higher than five state-of-the-art methods used for comparison. Comparison results demonstrate that MDAKRLS has faster computing speed under two kinds of frameworks. In addition, case studies of inflammatory bowel disease (IBD) and asthma further showed 19 (IBD), 19 (asthma) of the top 20 prediction disease-related microbes could be verified by previously published biological or medical literature.Conclusions: All the evaluation results adequately demonstrated that MDAKRLS has an effective and reliable prediction performance. It may be a useful tool to seek disease-related new microbes and help biomedical researchers to carry out follow-up studies.

18 July 2024 in BMC Biology
Verified
Journal Article
Open access
PDF file
YZYongdi Zhu
Yongdi Zhu
CNChunhui Ning
Chunhui Ning
NZNaiqian Zhang
Naiqian Zhang
MWMINGYI WANG
MINGYI WANG
YZYusen Zhang
Yusen Zhang
Background: Identification of potential drug-target interactions (DTIs) with high accuracy is a key step in drug discovery and repositioning, especially concerning specific drug targets. Traditional experimental methods for identifying the DTIs are arduous, time-intensive, and financially burdensome. In addition, robust computational methods have been developed for predicting the DTIs and are widely applied in drug discovery research. However, advancing more precise algorithms for predicting DTIs is essential to meet the stringent standards demanded by drug discovery. Results: We proposed a novel method called GSRF-DTI, which integrates networks with a deep learning algorithm to identify DTIs. Firstly, GSRF-DTI learned the embedding representation of drugs and targets by integrating multiple drug association information and target association information, respectively. Then, GSRF-DTI considered the influence of drug-target pair (DTP) association on DTI prediction to construct a drug-target pair network (DTP-NET). Next, we utilized GraphSAGE on DTP-NET to learn the potential features of the network and applied random forest (RF) to predict the DTIs. Furthermore, we conducted ablation experiments to validate the necessity of integrating different types of network features for identifying DTIs. It is worth noting that GSRF-DTI proposed three novel DTIs. Conclusions: GSRF-DTI not only considered the influence of the interaction relationship between drug and target but also considered the impact of DTP association relationship on DTI prediction. We initially use GraphSAGE to aggregate the neighbor information of nodes for better identification. Experimental analysis on Luo’s dataset and the newly constructed dataset revealed that the GSRF-DTI framework outperformed several state-of-the-art methods significantly.

1 January 2020 in Immunobiology
Verified
Journal Article
Closed access
SSShu-Li Shao
Shu-Li Shao
HCHai-Yan Cong
Hai-Yan Cong
MWMINGYI WANG
MINGYI WANG
PLPeng Liu
Peng Liu

1 July 2020 in Future Microbiology
Verified
Journal Article
Closed access
JBJinshuang Bo
Jinshuang Bo
SWShuai Wang
Shuai Wang
YBYanni Bi
Yanni Bi
SMShuqing Ma
Shuqing Ma
MWMINGYI WANG
MINGYI WANG
ZDZongjun Du
Zongjun Du
Eggerthella lenta is an emerging and uncommon human pathogen that has been under recognized due to the limitations of phenotypic identification. Here we describe two cases of bacteremia caused by E...